Published: 7 February 2026
Author(s): Michele Rossi, Enrico Tartaglia, Amir Askarinejad, Andrea Galeazzo Rigutini, Muath Alobaida, Anirudh Rao, Louise Oni, Claudio Ferri, Tommaso Bucci, Gregory Y.H. Lip
Section: Original Article
The risk-benefit profile of direct oral anticoagulants (DOACs) in kidney transplant recipients (KTRs) with atrial fibrillation (AF) remains under-investigated.
